Utilization of Wearable Technology for Screening, Monitoring, and Managing Atrial Fibrillation

Category	Detail
Condition	Atrial Fibrillation
Key Mechanisms	Wearable devices using photoplethysmography (PPG) and electrocardiography (ECG) for continuous monitoring.
Target Population	Individuals with atrial fibrillation, including those with subclinical cases.
Care Setting	Community screening, postoperative monitoring, and long-term patient management.

Atrial fibrillation is the most prevalent cardiac arrhythmia, affecting approximately 59.7 million individuals globally.
Wearable technology enhances the detection of paroxysmal and asymptomatic atrial fibrillation.
Integration of artificial intelligence in wearables facilitates remote monitoring and patient-clinician interactions.
Subclinical atrial fibrillation detection raises questions about anticoagulation initiation thresholds.
Standardized algorithms and validated hardware are essential for effective clinical implementation.

Implement wearable technology for continuous monitoring and timely intervention.

Increased detection of subclinical atrial fibrillation may complicate treatment decisions.

Patients with atrial fibrillation, including those with subclinical forms.

Personalized antithrombotic therapy based on continuous AF burden assessment.

Adopt multimodal wearable devices for comprehensive AF management.
Ensure interoperability of electronic health records for effective data sharing.
Focus on the continuous quantification of AF burden to guide therapy.

Clinical Scorecard: Utilization of Wearable Technology for Screening, Monitoring, and Managing Atrial Fibrillation